The success of Viagra initially drove a surge for pharma, but recent shifts present a complicated scenario for investors. Off-patent competitors are reducing profits, and continued patent challenges add further https://asiyakdft061972.livebloggs.com/47949790/the-blue-pill-and-the-pharmaceutical-industry-a-risky-play